Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance-Reference-Cited by-同舟云学术

Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance

Published:2011-06 Issue:26 Volume:29 Page:4378-4387
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kurz Xavier,Domergue François,Slattery Jim,Segec Andrej,Szmigiel Agnieszka,Hidalgo-Simon Ana

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference43 articles.

1. European Medicines Agency. Pandemic Influenza A(H1N1)v vaccines authorised via the core dossier procedure. Explanatory note on scientific considerations regarding the licensing of pandemic A(H1N1)v vaccines. EMEA/608259/2009 rev, http://www.ema.europa.eu/pdfs/human/pandemicinfluenza/60825909en.pdf [accessed 18.03.11].

2. European Medicines Agency. Committee for Human Medicinal Products (CHMP) Assessment report for Pandemrix. EMEA/CHMP/619109/2009, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000832/WC500095422.pdf [accessed 18.03.11].

3. European Medicines Agency. Committee for Human Medicinal Products (CHMP) Assessment report for Focetria. EMEA/CHMP/503605/2009, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000710/WC500023755.pdf [accessed 18.03.11].

4. European Medicines Agency. Committee for Human Medicinal Products (CHMP) Assessment report for Celvapan. EMEA/CHMP/629184/2009, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000982/WC500022669.pdf [accessed 18.03.11].

5. European Medicines Agency. CHMP recommendations for the pharmacovigilance plan as part of the risk management plan to be submitted with the marketing authorisation application for a pandemic influenza vaccine. Revision 1.1 adopted by CHMP on 24 September 2009. EMEA/359381/2009, http://www.ema.europa.eu/pdfs/human/pandemicinfluenza/35938109en.pdf [accessed 18.03.11].

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine;Drugs;2024-08-21

2. The readiness of the spontaneous reporting system for COVID-19 vaccines safety monitoring in Croatia;Acta Pharmaceutica;2023-06-01

3. Pandemic vaccines: a formidable challenge for pharmacovigilance;Nature Reviews Drug Discovery;2022-10-28

4. Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews;Frontiers in Immunology;2021-10-28

5. Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project;Drug Safety;2021-01-19